These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1423319)

  • 21. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China.
    Liu R; Yin LH; Pu YP
    Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetic polymorphism in cytochrome P450 2E1, salted food and colorectal cancer susceptibility: a case-control study].
    Yu WP; Chen K; Ma XY; Yao KY; Jiang QT; Zou Y; Zhou HG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 May; 38(3):162-6. PubMed ID: 15182482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphism at the P450IIE1 locus is not associated with alcoholic liver disease in Caucasian men.
    Carr LG; Hartleroad JY; Liang Y; Mendenhall C; Moritz T; Thomasson H
    Alcohol Clin Exp Res; 1995 Feb; 19(1):182-4. PubMed ID: 7771648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol-metabolizing enzyme polymorphisms and alcoholism in Japan.
    Maezawa Y; Yamauchi M; Toda G; Suzuki H; Sakurai S
    Alcohol Clin Exp Res; 1995 Aug; 19(4):951-4. PubMed ID: 7485844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5'-flanking region.
    Watanabe J; Hayashi S; Kawajiri K
    J Biochem; 1994 Aug; 116(2):321-6. PubMed ID: 7529759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease.
    Kato S; Onda M; Matsukura N; Tokunaga A; Tajiri T; Kim DY; Tsuruta H; Matsuda N; Yamashita K; Shields PG
    Pharmacogenetics; 1995; 5 Spec No():S141-4. PubMed ID: 7581484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.
    Liu S; Park JY; Schantz SP; Stern JC; Lazarus P
    Oral Oncol; 2001 Jul; 37(5):437-45. PubMed ID: 11377232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene].
    Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
    Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in alcohol metabolizing enzyme genes and alcoholic cirrhosis in Japanese patients: a multivariate analysis.
    Yamauchi M; Maezawa Y; Mizuhara Y; Ohata M; Hirakawa J; Nakajima H; Toda G
    Hepatology; 1995 Oct; 22(4 Pt 1):1136-42. PubMed ID: 7557863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer.
    Persson I; Johansson I; Bergling H; Dahl ML; Seidegård J; Rylander R; Rannug A; Högberg J; Sundberg MI
    FEBS Lett; 1993 Mar; 319(3):207-11. PubMed ID: 8096192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
    London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR
    Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese.
    Stephens EA; Taylor JA; Kaplan N; Yang CH; Hsieh LL; Lucier GW; Bell DA
    Pharmacogenetics; 1994 Aug; 4(4):185-92. PubMed ID: 7987402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population.
    Hiratsuka M; Takekuma Y; Endo N; Narahara K; Hamdy SI; Kishikawa Y; Matsuura M; Agatsuma Y; Inoue T; Mizugaki M
    Eur J Clin Pharmacol; 2002 Sep; 58(6):417-21. PubMed ID: 12242601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human cytochrome P450IIE1 gene: DraI polymorphism and susceptibility to cancer.
    Uematsu F; Kikuchi H; Motomiya M; Abe T; Ishioka C; Kanamaru R; Sagami I; Watanabe M
    Tohoku J Exp Med; 1992 Oct; 168(2):113-7. PubMed ID: 1363974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer.
    Uematsu F; Kikuchi H; Motomiya M; Abe T; Sagami I; Ohmachi T; Wakui A; Kanamaru R; Watanabe M
    Jpn J Cancer Res; 1991 Mar; 82(3):254-6. PubMed ID: 1673675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene.
    Hayashi S; Watanabe J; Kawajiri K
    J Biochem; 1991 Oct; 110(4):559-65. PubMed ID: 1778977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer.
    Wu X; Shi H; Jiang H; Kemp B; Hong WK; Delclos GL; Spitz MR
    Carcinogenesis; 1997 May; 18(5):967-73. PubMed ID: 9163682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
    Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
    PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.